Michael A. Narachi is a businessperson who has been at the helm of 6 different companies. Presently, he is President, Chief Executive Officer & Director at CODA Biotherapeutics, Inc. Mr. Narachi is also on the board of Biotechnology Innovation Organization and Ultragenyx Pharmaceutical, Inc.

In the past Mr. Narachi occupied the position of Chairman at Naryx Pharma, Inc., Chairman, President & Chief Executive Officer of Ren Pharmaceuticals, Inc., Vice President for Amgen, Inc., Director-Clinical Operations at Thousand Oaks Corp., Chairman at Celladon Corp., Director at AMAG Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Orexigen Therapeutics, Inc. and Vice President-Development at Amgen KK.

Mr. Narachi received an undergraduate degree and a graduate degree from the University of California, Davis and an MBA from UCLA Anderson School of Management.